Skip to main content
Clinical Trials/NCT01289288
NCT01289288
Completed
Phase 1

A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese

Georgetown University2 sites in 1 country480 target enrollmentJuly 2007

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Georgetown University
Enrollment
480
Locations
2
Primary Endpoint
Receipt of CRC screening
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The objective of this study is to test whether a culturally-tailored in-office based intervention have impact on increasing Chinese physician's recommendation of colorectal cancer (CRC) screening to their nonadherent Chinese patients.

Special aims are to:

  1. Evaluate the efficacy of a culturally-tailored physician intervention on increasing non-adherent Chinese American's patients' CRC screening rate.
  2. Identify factors that mediate or moderate the intervention effects. For example, patients who hold an eastern cultural view or are less acculturated will be more likely to benefit from the intervention than patients who hold a western view or who are more acculturated.

Detailed Description

This study is a randomized controlled trial aiming to test the effect of the culturally-tailored in-office based intervention on physicians. A total of 24 Chinese physicians in the Washington DC and Philadelphia areas and a total of 24 eligible Chinese patients from each physician will be recruited for this study. Physicians and their patients are randomized into two groups: A and B. Physician in the intervention group (A) will receive mailed printed materials including a CRC physician guide, patient brochure, flip chart and a poster and two sessions of in-office training aimed to reinforce learning of the topic covered by the mailed materials and provide physicians with hands-on experience in using communication skills with standardized patients. Physicians in the control group (B) will receive nothing until the end of the study. Patients will be followed 12-month later after their completion of the baseline survey and their self-reported CRC screening status will be verified by chart audit.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
July 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Judy Wang

Assistant Professor

Georgetown University

Eligibility Criteria

Inclusion Criteria

  • For Physicians
  • are Chinese American,
  • practice primary care,
  • have a least 75 Chinese patients aged 50 and older in their practice,
  • can communicate with patients in Chinese (Mandarin, Cantonese, etc.)
  • For Patients
  • visiting the participating physician at least once in the past 2 years,
  • are Chinese Americans,
  • are 50 years and older,
  • never had any CRC screening or are overdue for screening.

Exclusion Criteria

  • For Patients:
  • have a colorectal polyp, CRC cancer, or a family history of CRC (first degree relative), and
  • had updated CRC screening (FOBT within one year, colonoscopy within 10 years, sigmoidoscopy within 5 years and double-contrast barium enema within 5 years).

Outcomes

Primary Outcomes

Receipt of CRC screening

Time Frame: 12 months

Nonadherent Chinese American patient's CRC screening rates.

Study Sites (2)

Loading locations...

Similar Trials